Bernstein SocGen Group analyst Courtney Breen reiterated an Outperform rating and $1,300.00 price target on Eli Lilly (NYSE: LLY).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'February 5, 2026 12:35 PM Wells Fargo on Eli Lilly (LLY): 'Compounders Strike Again, but We See Little Risk to Near-Term Growth'February 5, 2026 10:10 AM